These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 9427768

  • 1. Prognostic significance of serum p53 antibodies in squamous cell carcinoma of the lung.
    Komiya T, Hirashima T, Takada M, Masuda N, Yasumitsu T, Nakagawa K, Hosono Y, Kikui M, Tsuji S, Fukuoka M, Kawase I.
    Anticancer Res; 1997; 17(5B):3721-4. PubMed ID: 9427768
    [Abstract] [Full Text] [Related]

  • 2. The role of circulating anti-p53 antibodies in patients with advanced non-small cell lung cancer and their correlation to clinical parameters and survival.
    Bergqvist M, Brattström D, Larsson A, Hesselius P, Brodin O, Wagenius G.
    BMC Cancer; 2004 Sep 14; 4():66. PubMed ID: 15367333
    [Abstract] [Full Text] [Related]

  • 3. Serum p53 antibody is a useful tumor marker in superficial esophageal squamous cell carcinoma.
    Shimada H, Takeda A, Arima M, Okazumi S, Matsubara H, Nabeya Y, Funami Y, Hayashi H, Gunji Y, Suzuki T, Kobayashi S, Ochiai T.
    Cancer; 2000 Oct 15; 89(8):1677-83. PubMed ID: 11042560
    [Abstract] [Full Text] [Related]

  • 4. Presence of serum anti-p53 antibodies is associated with pleural effusion and poor prognosis in lung cancer patients.
    Lai CL, Tsai CM, Tsai TT, Kuo BI, Chang KT, Fu HT, Perng RP, Chen JY.
    Clin Cancer Res; 1998 Dec 15; 4(12):3025-30. PubMed ID: 9865916
    [Abstract] [Full Text] [Related]

  • 5. The detection of quantitative serum p53 protein in lung cancer.
    Sen E, Gönüllü U, Akar N.
    Tuberk Toraks; 2005 Dec 15; 53(3):231-7. PubMed ID: 16258881
    [Abstract] [Full Text] [Related]

  • 6. Serum anti-p53 antibodies as a diagnostic tumor marker: observations in patients with malignant and premalignant oral cavity lesions.
    Porrini R, Vercellino V, Rocchetti V, Renò F, Giorda E, Pomato E, Cannas M, Sabbatini M.
    Minerva Stomatol; 2010 May 15; 59(5):233-9, 239-43. PubMed ID: 20502428
    [Abstract] [Full Text] [Related]

  • 7. Serum anti-p53 antibody detection in carcinomas and the predictive values of serum p53 antibodies, carcino-embryonic antigen and carbohydrate antigen 12-5 in the neoadjuvant chemotherapy treatment for III stage non-small cell lung cancer patients.
    Yu DH, Li JH, Wang YC, Xu JG, Pan PT, Wang L.
    Clin Chim Acta; 2011 May 12; 412(11-12):930-5. PubMed ID: 21277290
    [Abstract] [Full Text] [Related]

  • 8. Autoantibodies against P53 protein in patients with transitional cell carcinoma of the bladder.
    Sanchez-Carbayo M, Chulia MT, Niveiro M, Aranda I, Mira A, Soria F.
    Anticancer Res; 1999 May 12; 19(4C):3531-7. PubMed ID: 10629648
    [Abstract] [Full Text] [Related]

  • 9. Mutations in exon 7 and 8 of p53 as poor prognostic factors in patients with non-small cell lung cancer.
    Huang C, Taki T, Adachi M, Konishi T, Higashiyama M, Miyake M.
    Oncogene; 1998 May 14; 16(19):2469-77. PubMed ID: 9627113
    [Abstract] [Full Text] [Related]

  • 10. Alteration of autoantibodies against p53 in Taiwanese lung cancer patients undergoing chemotherapy.
    Lee YL, Shih CM, Chiou HL, Shiau MY, Chang GC, Chang YH.
    Clin Chim Acta; 2004 Nov 14; 349(1-2):87-96. PubMed ID: 15469860
    [Abstract] [Full Text] [Related]

  • 11. Prognostic significance of the tumor suppressor gene maspin in non-small cell lung cancer.
    Hirai K, Koizumi K, Haraguchi S, Hirata T, Mikami I, Fukushima M, Yamagishi S, Kawashima T, Okada D, Shimizu K, Kawamoto M.
    Ann Thorac Surg; 2005 Jan 14; 79(1):248-53. PubMed ID: 15620951
    [Abstract] [Full Text] [Related]

  • 12. P53 auto-antibodies in non-small cell lung cancer patients can predict increased life expectancy after radiotherapy.
    Bergqvist M, Brattström D, Larsson A, Holmertz J, Hesselius P, Rosenberg L, Wagenius G, Brodin O.
    Anticancer Res; 1998 Jan 14; 18(3B):1999-2002. PubMed ID: 9677456
    [Abstract] [Full Text] [Related]

  • 13. The expression of cyclins D1 and E in predicting short-term survival in squamous cell carcinoma of the lung.
    Anton RC, Coffey DM, Gondo MM, Stephenson MA, Brown RW, Cagle PT.
    Mod Pathol; 2000 Nov 14; 13(11):1167-72. PubMed ID: 11106072
    [Abstract] [Full Text] [Related]

  • 14. Prognostic significance of expression of p53 oncoprotein in primary (stage I-IIIa) non-small cell lung cancer.
    Tan DF, Li Q, Rammath N, Beck A, Wiseman S, Anderson T, al-Salameh A, Brooks J, Bepler G.
    Anticancer Res; 2003 Nov 14; 23(2C):1665-72. PubMed ID: 12820438
    [Abstract] [Full Text] [Related]

  • 15. Analysis of p53 antibody response in patients with squamous cell carcinoma of the head and neck.
    Lavieille JP, Lubin R, Soussi T, Reyt E, Brambilla C, Riva C.
    Anticancer Res; 1996 Nov 14; 16(4C):2385-8. PubMed ID: 8816839
    [Abstract] [Full Text] [Related]

  • 16. Prognostic significance of three hepatitis markers (p53 antibodies, vascular endothelial growth factors and alpha fetoprotein) in patients with hepatocellular carcinoma.
    Gadelhak NA, Gadelhak SA, El-Morsi DA, Abdelaziz MM, Abbas AT, El-Emshaty HM.
    Hepatogastroenterology; 2009 Nov 14; 56(94-95):1417-24. PubMed ID: 19950803
    [Abstract] [Full Text] [Related]

  • 17. The utility of p53 immunostaining of transbronchial biopsy specimens of lung cancer: p53 overexpression predicts poor prognosis and chemoresistance in advanced non-small cell lung cancer.
    Kawasaki M, Nakanishi Y, Kuwano K, Yatsunami J, Takayama K, Hara N.
    Clin Cancer Res; 1997 Jul 14; 3(7):1195-200. PubMed ID: 9815799
    [Abstract] [Full Text] [Related]

  • 18. Association of positive serum anti-p53 antibodies with poor prognosis in bladder cancer patients.
    Gumus E, Erdamar S, Demirel G, Horasanli K, Kendirci M, Miroglu C.
    Int J Urol; 2004 Dec 14; 11(12):1070-7. PubMed ID: 15663677
    [Abstract] [Full Text] [Related]

  • 19. Prognostic value of serum p53 antibodies in patients with resected non-small cell lung cancer.
    Laudanski J, Burzykowski T, Niklinska W, Chyczewski K, Furman M, Niklinski J.
    Lung Cancer; 1998 Dec 14; 22(3):191-200. PubMed ID: 10048472
    [Abstract] [Full Text] [Related]

  • 20. Deregulated p21(WAF1) overexpression impacts survival of surgically resected esophageal squamous cell carcinoma patients.
    Goan YG, Hsu HK, Chang HC, Chou YP, Chiang KH, Cheng JT.
    Ann Thorac Surg; 2005 Sep 14; 80(3):1007-16. PubMed ID: 16122475
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.